Search results for "Soman"

showing 10 items of 13 documents

Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations

2015

Objective: The studies that have extensively evaluated the relation between adipokines and metabolic parameters in acromegaly treatment are quite discordant. We aimed to evaluate and correlate a set of selected adipokines, known to have a metabolic role, with the disease activity, metabolic status and treatment modalities. Design: Data of 56 consecutive acromegalic patients (31 M and 25 F; aged 54 ± 12 years), admitted to the section of Endocrinology of the University of Palermo during the years 2005-2014, including 16 newly diagnosed untreated (ND), 21 during therapy with somatostatin analogues (SA), 12 with pegvisomant (PE) and 7 after surgical treatment (SU), grouped into uncontrolled (g…

AdultLeptinMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismAdipokineFatty Acids NonesterifiedSettore MED/13 - EndocrinologiaInsulin resistanceEndocrinologyAcromegaly; Adipokines; Growth hormone; Endocrinology; Endocrinology Diabetes and MetabolismAdipokinesInternal medicineAdipokineAcromegalyMedicineHumansNicotinamide PhosphoribosyltransferaseGrowth hormoneTriglyceridesAdiposityAgedLeptin receptorAdiponectinbusiness.industryLeptinCholesterol HDLMiddle Agedmedicine.diseaseEndocrinologyCross-Sectional StudiesPegvisomantAcromegalyCytokinesResistinFemaleInsulin ResistancebusinessBiomarkersmedicine.drug
researchProduct

Selective chromo-fluorogenic detection of DFP (a Sarin and Soman mimic) and DCNP (a Tabun mimic) with a unique probe based on a boron dipyrromethene …

2014

[EN] A novel colorimetric probe (P4) for the selective differential detection of DFP (a Sarin and Soman mimic) and DCNP (a Tabun mimic) was prepared. Probe P4 contains three reactive sites; i.e. (i) a nucleophilic phenol group able to undergo phosphorylation with nerve gases, (ii) a carbonyl group as a reactive site for cyanide; and (iii) a triisopropylsilyl (TIPS) protecting group that is known to react with fluoride. The reaction of P4 with DCNP in acetonitrile resulted in both the phosphorylation of the phenoxy group and the release of cyanide, which was able to react with the carbonyl group of P4 to produce a colour modulation from pink to orange. In contrast, phosphorylation of P4 with…

Boron CompoundsSarinORGANOPHOSPHATE PESTICIDESAcetonitrilesCyanideSomanColorSilica GelNERVE AGENTSCHEMICAL WARFARE AGENTSBiochemistryACETYLCHOLINESTERASESubstrate Specificitychemistry.chemical_compoundQUIMICA ORGANICALimit of DetectionSomanmedicineSENSORSNANOPARTICLESPhenolOrganic chemistryHumansChemical Warfare AgentsPhysical and Theoretical ChemistryPhosphorylationProtecting groupTabunNerve agentLANTHANIDE IONSReagent StripsRHODAMINE-BOrganic ChemistryQUIMICA INORGANICAMolecular MimicryMembranes ArtificialSarinOrganophosphatesFLUORESCENTchemistryMolecular ProbesSolventsColorimetryBODIPYFIELD-EFFECT TRANSISTORSNuclear chemistrymedicine.drugOrganicbiomolecular chemistry
researchProduct

A Rapid and Sensitive Strip-Based Quick Test for Nerve Agents Tabun, Sarin, and Soman Using BODIPY-Modified Silica Materials

2016

Test strips that in combination with a portable fluorescence reader or digital camera can rapidly and selectively detect chemical warfare agents (CWAs) such as Tabun (GA), Sarin (GB), and Soman (GD) and their simulants in the gas phase have been developed. The strips contain spots of a hybrid indicator material consisting of a fluorescent BODIPY indicator covalently anchored into the channels of mesoporous SBA silica microparticles. The fluorescence quenching response allows the sensitive detection of CWAs in the mu g m(-3) range in a few seconds.

Boron CompoundsSarinSilicon dioxideSomanAnalytical chemistrynerve gases010402 general chemistry01 natural sciencesCatalysischemistry.chemical_compoundSomanQUIMICA ANALITICAmedicineChemical Warfare AgentsTabunNerve agenthybrid sensor materialsChromatography010405 organic chemistryOrganic ChemistryQUIMICA INORGANICAGeneral ChemistrySilicon DioxideFluorescenceSarinOrganophosphates0104 chemical scienceschemistrychemical warfare agentstest strip analysisProthrombin TimefluorescenceBODIPYMesoporous materialNerve Agentsmedicine.drug
researchProduct

Selective opening of nanoscopic capped mesoporous inorganic materials with nerve agent simulants; an application to design chromo-fluorogenic probes.

2011

A hybrid nanoscopic capped mesoporous material, that is selectively opened in the presence of nerve agent simulants, has been prepared and used as a probe for the chromo-fluorogenic detection of these chemicals. © 2011 The Royal Society of Chemistry.

INGENIERIA DE LA CONSTRUCCIONMaterials scienceSilicon dioxideSomanNanotechnologyCatalysisArticleMolecular hybridizationchemistry.chemical_compoundQUIMICA ORGANICAMCM-41QUIMICA ANALITICAMaterials ChemistrymedicineOrganometallic CompoundsNanotechnologyChemical Warfare AgentsNanoscopic scaleTabunGroup 2 organometallic chemistryNerve agentFluorescent DyesSelective openingChemical warfare agentQUIMICA INORGANICAMetals and AlloysHydrogen BondingGeneral ChemistrySilicon DioxideSarinMcm 41Surfaces Coatings and FilmsElectronic Optical and Magnetic MaterialschemistryCeramics and CompositesDrug determinationInorganic materialsColorimetryMesoporous materialControlled studyPorositymedicine.drugChemical communications (Cambridge, England)
researchProduct

Janus kinase (JAK) 2 V617F mutation as the cause of primary thrombocythemia in acromegaly with severe visceromegaly and divergence between growth hor…

2012

OBJECTIVE: An increased prevalence of hematological abnormalities is reported in acromegaly, but to date no reports about the presence of the Janus Kinase (JAK) 2 mutation in acromegalic patients have been described. DESIGN: We report the complex clinical presentation of the unique case, never described, of acromegaly due to GH-secreting pituitary adenoma associated with JAK2 V617F mutation. RESULTS: The patient shows primary thrombocythemia and myelofibrosis, due to JAK2 V617F mutation, severe visceromegaly and a peculiar clinical course of the disease characterized by discrepant values of GH and IGF-1 during somatostatin analog (SA) treatment despite a significant reduction in pituitary a…

Malemedicine.medical_specialtyTime FactorsEndocrinology Diabetes and MetabolismGrowth hormone receptorAcromegaly HGH IGF-1GastroenterologySettore MED/13 - EndocrinologiaCohort StudiesEndocrinologyPituitary adenomahemic and lymphatic diseasesInternal medicineAcromegalymedicineAnimalsHumansPituitary NeoplasmsInsulin-Like Growth Factor IRadiometryMyelofibrosisAgedJanus kinase 2biologyHuman Growth HormonePlatelet Countbusiness.industryJanus Kinase 2medicine.diseaseAcromegaly Growth hormone Insulin-like growth factor-1 Janus kinase 2 Growth hormone receptorEndocrinologyAcromegalyMutationPegvisomantbiology.proteinJanus kinasebusinessVisceromegalyFollow-Up StudiesThrombocythemia Essentialmedicine.drug
researchProduct

Reversed Enantioselectivity of Diisopropyl Fluorophosphatase against Organophosphorus Nerve Agents by Rational Design

2009

Diisopropyl fluorophosphatase (DFPase) from Loligo vulgaris is an efficient and robust biocatalyst for the hydrolysis of a range of highly toxic organophosphorus compounds including the nerve agents sarin, soman, and cyclosarin. In contrast to the substrate diisopropyl fluorophosphate (DFP) the nerve agents possess an asymmetric phosphorus atom, which leads to pairs of enantiomers that display markedly different toxicities. Wild-type DFPase prefers the less toxic stereoisomers of the substrates which leads to slower detoxification despite rapid hydrolysis. Enzyme engineering efforts based on rational design yielded two quadruple enzyme mutants with reversed enantioselectivity and overall en…

Models MolecularSarinStereochemistryRational designCyclosarinStereoisomerismGeneral ChemistryNervous SystemBiochemistryCatalysisKineticschemistry.chemical_compoundOrganophosphorus CompoundsPhosphoric Triester HydrolasesColloid and Surface ChemistrychemistrySomanHydrolasemedicineDiisopropyl fluorophosphateChemical Warfare AgentsCrystallizationDiisopropyl-fluorophosphatasemedicine.drugNerve agentJournal of the American Chemical Society
researchProduct

Acetylcholinesterase-Capped Mesoporous Silica Nanoparticles That Open in the Presence of Diisopropylfluorophosphate (a Sarin or Soman Simulant)

2016

Mesoporous silica nanoparticles loaded with rhodamine B and capped with acetylcholinesterase are able to be selectively opened and deliver their cargo in the presence of nerve agent simulant diisopropyl fluorophosphate (DFP).

NANOCAPSULESRESPONSIVE CONTROLLED-RELEASESarinGATED MATERIALSNanoparticle02 engineering and technologyCHEMICAL WARFARE AGENTS010402 general chemistry01 natural sciencesBiochemistryNanocapsuleschemistry.chemical_compoundQUIMICA ORGANICADESIGNSomanmedicineRhodamine BOrganic chemistryDRUG-DELIVERYPhysical and Theoretical ChemistryNerve agentNANOCONTAINERSChemistryQUIMICA INORGANICAOrganic ChemistryDNAMesoporous silica021001 nanoscience & nanotechnologyGUEST MOLECULES0104 chemical sciencesDiisopropyl fluorophosphateDCNP0210 nano-technologymedicine.drugNuclear chemistryOrganic Letters
researchProduct

Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report

2018

Abstract Background The approach to acromegalic patients with persistent acromegaly after surgery and inadequate response to first-generation somatostatin receptor ligands (SRLs) should be strictly tailored. Current options include new pituitary surgery and/or radiosurgery, or alternative medical treatment with SRLs high dose regimens, pegvisomant (PEG) as monotherapy, or combined therapy with the addition of PEG or cabergoline to SRLs. A new pharmacological approach includes pasireotide, a second-generation SRL approved for patients who do not adequately respond to surgery and/or for whom surgery is not an option. No reports on efficacy and safety of combined therapy with pasireotide and p…

OncologyAdultMalemedicine.medical_specialtyCabergolineEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPegvisomant030209 endocrinology & metabolismCase ReportAntineoplastic Agentslcsh:Diseases of the endocrine glands. Clinical endocrinologyRadiosurgerySettore MED/13 - Endocrinologia03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCombined treatmentCabergolineInternal medicineAcromegalymedicineHumansErgolinesSalvage TherapyCotreatmentlcsh:RC648-665Medical treatmentSomatostatin receptorbusiness.industryHuman Growth HormoneGeneral Medicinemedicine.diseasePrognosisResistantPasireotideHormonesPasireotidechemistry030220 oncology & carcinogenesisPegvisomantAcromegalyDrug Therapy CombinationAcromegaly; Cotreatment; Pasireotide; Pegvisomant; ResistantbusinessSomatostatinmedicine.drugBMC Endocrine Disorders
researchProduct

A Chromogenic Probe for the Selective Recognition of Sarin and Soman Mimic DFP

2014

The synthesis, characterization and sensing features of a novel probe 1 for the selective chromogenic recognition of diisopropylfluorophosphate (DFP), a sarin and soman mimic, in 99:1 (v/ v) water/acetonitrile and in the gas phase is reported. Colour modulation is based on the combined reaction of phosphorylation of 1 and fluoride-induced hydrolysis of a silyl ether moiety. As fluoride is a specific reaction product of the reaction between DFP and the OH group, the probe shows a selective colour modulation in the presence of this chemical. Other nerve agent simulants, certain anions, oxidant species and other organophosphorous compounds were unable to induce colour changes in 1. This is one…

SarinAqueous solutionsomanChemistryChromogenicQUIMICA INORGANICAContext (language use)General Chemistrynerve agentsCommunicationsToxicologysarinchemistry.chemical_compoundQUIMICA ORGANICASomanmedicineMoietydiisopropylfluorophosphatechromogenic probeNerve agentmedicine.drugNuclear chemistryTabun
researchProduct

In vitro and in vivo efficacy of PEGylated diisopropyl fluorophosphatase (DFPase)

2011

Highly toxic organophosphorus compounds that irreversibly inhibit the enzyme acetycholinesterase (AChE), including nerve agents like tabun, sarin, or soman, still pose a credible threat to civilian populations and military personnel. New therapeutics that can be used as a pretreatment or after poisoning with these compounds, complementing existing treatment schemes such as the use of atropine and AChE reactivating oximes, are currently the subject of intense research. A prominent role among potential candidates is taken by enzymes that can detoxify nerve agents by hydrolysis. Diisopropyl fluorophosphatase (DFPase) from the squid Loligo vulgaris is known to effectively hydrolyze DFP and the …

SarinPharmaceutical ScienceIn vitroAnalytical Chemistrychemistry.chemical_compoundchemistryBiochemistryIn vivoSomanmedicinePEGylationEnvironmental ChemistryDiisopropyl-fluorophosphataseSpectroscopyNerve agentmedicine.drugTabunDrug Testing and Analysis
researchProduct